← Open Payments lookup

DIEM CHU: Open Payments

NPI 1225184955 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,322 in 53 payments from 16 companies in 2025. Trend: 2023 $1,735 · 2024 $3,661 · 2025 $3,322

Food & beverage: $2,985Education: $337
CompanyPaymentsAmount
Incyte Corporation10$807
Astellas Pharma US Inc12$651
Gilead Sciences, Inc.3$332
Janssen Biotech, Inc.4$294
Takeda Pharmaceuticals U.S.A., Inc.4$220
SOBI, INC3$176
ABBVIE INC.2$150
Syndax Pharmaceuticals, Inc.3$138
PFIZER INC.1$118
Merck Sharp & Dohme LLC3$102

Products named: NIKTIMVO, Cresemba, Jakafi, Xospata, Vemlidy, LIVTENCITY, Vonjo, DARZALEX.

Industry payments across TX — which companies pay providers there.